05/01/2013 - 3:19pm

Bayer HealthCare will buy birth-control product maker Conceptus for $1.1 billion, the companies said.

05/01/2013 - 11:17am

Prasco Labs has signed a deal with WellSpring Pharmaceutical Corp. to market an authorized generic version of a drug for a rare tumor disorder.

05/01/2013 - 11:01am

Drug maker Actavis has acquired rights to a treatment for an experimental bacterial vaginosis from Valeant Pharmaceuticals International for about $55 million, the drug makers said.

04/30/2013 - 12:30pm

The Food and Drug Administration has approved a new treatment for a genetic disorder that affects about 500 people in the United States and 3,000 worldwide, the agency said Tuesday.

04/30/2013 - 11:57am

The Food and Drug Administration has approved a drug made by Genentech for a rare form of arthritis in children, the company said Tuesday.

04/30/2013 - 10:47am

The Food and Drug Administration has approved a drug that reverses the effects of anticoagulant drugs in patients who have suffered acute major bleeding, the agency said.

04/30/2013 - 10:13am

The Food and Drug Administration declined to approve two drugs for HIV made by Gilead Sciences for which the company was seeking approval for use as part of treatment regimens.

04/29/2013 - 2:09pm

A proposal by Canadian drug maker Valeant Pharmaceuticals International to purchase generic drug maker Actavis has fallen through, according to published reports.

04/26/2013 - 11:47am

Medical products manufacturer Covidien's pharmaceutical division is expanding an initiative to collect unused and unwanted medications.